Testing effectiveness (Phase 2)Study completedNCT01212744
What this trial is testing
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
Who this might be right for
Phenylketonuria
BioMarin Pharmaceutical 16